Article
GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.-1339A>G Polymorphisms and Severity of Vomiting in Head and Neck Cancer Patients treated with Cisplatin Chemoradiation.
Basic & clinical pharmacology & toxicology - 1 Dec 2017
Carron Juliana, Lopes-Aguiar Leisa, Costa Ericka Francislaine Dias, Nogueira Guilherme Augusto Silva, Lima Tathiane Regine Penna, Pincinato Eder Carvalho, Visacri Marilia Berlofa, Quintanilha Júlia Coelho França, Moriel Patrícia, Lourenço Gustavo Jacob, Lima Carmen Silvia Passos
Abstract excerpt
Cisplatin (CDDP) chemotherapy associated with radiation (RT) has been used in advanced head and neck squamous cell carcinoma (HNSCC) patients, and vomiting is a common side effect during treatment. This prospective study aimed to identify the roles of GSTM1 and GSTT1 (presents or nulls), GSTP1 c.313A>G, XPC c.2815A>C, XPD c.934G>A and c.2251A>C, XPF c.2505T>C, ERCC1 c.354C>T, MLH1 c.-93G>A, MSH2 c.211 + 9C>G,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
